Epidemiology, risk factors, and clinical outcomes of neonatal jaundice: a prospective observational study
Learnovate-International · 2025
DOI: 10.70604/learnint.v2i3.85 ↗Kurz gefasst
Fachartikel in der Zeitschrift Learnovate-International, 2025. Verfasst von Swapna Bujagouni und 6 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Neonatal jaundice is a highly common condition affecting over 80% of full-term and preterm infants, usually appearing within 2–4 days of birth due to increased total serum bilirubin (TSB) caused by heightened red blood cell breakdown and immature liver clearance. While most cases resolve spontaneously within 1–2 weeks, severe unconjugated hyperbilirubinaemia can lead to bilirubin encephalopathy, seizures, developmental delays, or even death, making early detection and treatment essential. This prospective six-month study was carried out in the Department of Paediatrics at SVS Medical College and Hospital, Mahabubnagar, involving 80 neonates to assess diagnosis, treatment approaches, and outcomes. Data collected included demographic details, bilirubin levels, type and severity of jaundice, and therapeutic responses. Results indicated a slight male predominance (53%) with the highest incidence in infants aged 1–10 days, while preterm infants were most affected (38%), highlighting their increased vulnerability due to immature liver function. The distribution of causes showed physiological jaundice and breast milk jaundice (25% each), pathological jaundice (20%), Rh incompatibility (17%), and ABO incompatibility (13%). Clinical presentation ranged from facial to generalised involvement, reflecting severity. Phototherapy was the main treatment (49%), followed by observation (31%), intravenous immunoglobulin (IVIG) (15%), and exchange transfusion (5%), emphasising its crucial role in preventing kernicterus. In conclusion, the study underscores that neonatal jaundice, although common, necessitates vigilant monitoring, early screening, and prompt intervention to minimise morbidity, especially in high-risk preterm infants.
Zitieren
APA
Bujagouni, S., Thagaram, C., Nagilla, S., Tokala, H. R., Acchugatla, S., Surabhi, H., & Hajira, B. (2025). Epidemiology, risk factors, and clinical outcomes of neonatal jaundice: a prospective observational study. Learnovate-International. https://doi.org/10.70604/learnint.v2i3.85
Vancouver
Bujagouni S, Thagaram C, Nagilla S, Tokala HR, Acchugatla S, Surabhi H, et al. Epidemiology, risk factors, and clinical outcomes of neonatal jaundice: a prospective observational study. Learnovate-International. 2025. doi:10.70604/learnint.v2i3.85
BibTeX
@article{Bujagouni2025,
author = {Bujagouni, Swapna and Thagaram, Chandu and Nagilla, Saidulu and Tokala, Haritha Reddy and Acchugatla, Shivarani and Surabhi, Harsha and Hajira, Begum},
title = {Epidemiology, risk factors, and clinical outcomes of neonatal jaundice: a prospective observational study},
journal = {Learnovate-International},
year = {2025},
doi = {10.70604/learnint.v2i3.85}
}
EUVIMED